We observed a superior reduction in the amount of viable immune cells, as well as reductions in the percentage of CD4+ T-cells in co-cultures with ser/gly producing NKX2-1 lung cancer cells (Supplementary Fig. S8). This evidence concerns the gene NKX2-1 and lung cancer.